BDX
$BDX
Becton, Dickinson and Company
Medical technology company making syringes, diagnostics, and infusion systems.
Healthcare$149.31
+0.27 (+0.18%)
Day Range$147.19 - $150.19
Prev Close$149.04
Analyst Rating
Buy
10 Buy / 11 Hold / 0 Sell
Subscribers
0
Tracking this ticker
Next Report
—
Weekly updates
Latest Report
BDX: AI Launch vs Revenue Headwinds
Becton Dickinson ($BDX) sits at a crossroads — new AI-enabled product launches could drive medium-term margin recovery, while FY26 revenue pressure and recent underperformance keep upside limited near term. Analysts remain mostly positive but the company will need clearer execution and better top-line visibility to re-rate.
Apr 6, 2026